Artivion Inc (NYSE:AORT) — Market Cap & Net Worth
Market Cap & Net Worth: Artivion Inc (AORT)
Artivion Inc (NYSE:AORT) has a market capitalization of $1.02 Billion ($1.02 Billion) as of June 16, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #9007 globally and #2495 in its home market, demonstrating a 4.72% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Artivion Inc's stock price $21.07 by its total outstanding shares 48543350 (48.54 Million). Review Artivion Inc (AORT) financial obligations to assess the company's total debt and financial obligations.
Artivion Inc Market Cap History: 2015 to 2026
Artivion Inc's market capitalization history from 2015 to 2026. Data shows growth from $523.30 Million to $1.02 Billion (6.94% CAGR).
Index Memberships
Artivion Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P Small-Cap 600 Index
SML
|
$1.65 Trillion | 0.08% | #467 of 602 |
Weight: Artivion Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Artivion Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Artivion Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
5.02x
Artivion Inc's market cap is 5.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
226.66x
Artivion Inc's market cap is 226.66 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $929.61 Million | $180.38 Million | $10.78 Million | 5.15x | 86.25x |
| 2017 | $929.61 Million | $189.70 Million | $3.70 Million | 4.90x | 250.97x |
| 2018 | $1.38 Billion | $262.84 Million | -$3.81 Million | 5.24x | N/A |
| 2019 | $1.32 Billion | $276.22 Million | $1.72 Million | 4.76x | 764.56x |
| 2020 | $1.15 Billion | $253.23 Million | -$16.68 Million | 4.53x | N/A |
| 2021 | $987.86 Million | $298.84 Million | -$14.83 Million | 3.31x | N/A |
| 2022 | $588.35 Million | $313.79 Million | -$19.19 Million | 1.87x | N/A |
| 2023 | $867.96 Million | $354.00 Million | -$30.69 Million | 2.45x | N/A |
| 2024 | $1.39 Billion | $388.54 Million | -$13.36 Million | 3.57x | N/A |
| 2025 | $2.21 Billion | $441.33 Million | $9.77 Million | 5.02x | 226.66x |
Competitor Companies of AORT by Market Capitalization
Companies near Artivion Inc in the global market cap rankings as of June 16, 2026.
Key companies related to Artivion Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #151 globally with a market cap of $154.19 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #205 globally with a market cap of $117.85 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #237 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #245 globally with a market cap of $103.20 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #151 | Abbott Laboratories | NYSE:ABT | $154.19 Billion | $88.67 |
| #205 | Stryker Corporation | NYSE:SYK | $117.85 Billion | $307.94 |
| #237 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #245 | Medtronic PLC | NYSE:MDT | $103.20 Billion | $80.38 |
Artivion Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Artivion Inc's market cap moved from $523.30 Million to $ 1.02 Billion, with a yearly change of 6.94%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.02 Billion | -53.80% |
| 2025 | $2.21 Billion | +59.53% |
| 2024 | $1.39 Billion | +59.90% |
| 2023 | $867.96 Million | +47.52% |
| 2022 | $588.35 Million | -40.44% |
| 2021 | $987.86 Million | -13.81% |
| 2020 | $1.15 Billion | -12.85% |
| 2019 | $1.32 Billion | -4.55% |
| 2018 | $1.38 Billion | +48.20% |
| 2017 | $929.61 Million | 0.00% |
| 2016 | $929.61 Million | +77.64% |
| 2015 | $523.30 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 16th, 2026 the market cap of Artivion Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.02 Billion USD |
| MoneyControl | $1.02 Billion USD |
| MarketWatch | $1.02 Billion USD |
| marketcap.company | $1.02 Billion USD |
| Reuters | $1.02 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Artivion Inc
Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; Chord-X ePTFE sutures; pyrolytic carbon coating services; E-vita Open NEO, a hybrid stent graft; Arcevo, an LSA hybrid stent graft system; AMDS hybrid… Read more